Japan's Taisho in lead to buy Paras Pharma

Japan's Taisho Pharmaceuticals has emerged the top bidder to buy a majority stake in Indian drugmaker Paras Pharmaceuticals, which owns popular brands such as anti-cold medication D'Cold and pain relieving ointment Moov, the Economic Times says. Report

Suggested Articles

Johnson & Johnson and Bayer’s Xarelto is working to reverse a sales slide, and a new indication could help.

AZ's FluMist will be dramatically limited in the U.S. this flu season because of production problems, a spokeswoman said.

To get its $12 billion opioid deal off the ground, Purdue Pharma pushed for a stay on thousands of lawsuits against it. Last week, a judge signed off.